Microbiota in Dietary Approach to Obesity

Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (Other)
Overall Status
Completed
CT.gov ID
NCT04453150
Collaborator
(none)
150
1
5
29
5.2

Study Details

Study Description

Brief Summary

Main aim: Study the anthropometric, metabolic, cardiovascular and neurocognitive and gut microbiota changes of different approaches for the weight reduction that increase the ketone bodies in a different proportion in relation to the classic hypocaloric diet.

Objective 1: Study the effect of hypocaloric diets that increase the ketone bodies on gut microbiota and its relationship with anthropometric changes and of the Brown adipose tissue, Objective 2: with the metabolic and inflammatory changes, Objective 3: on the cardiovascular system, Objective 4: on the neurocognition, Objective 5: if they are associated to epigenetic changes that may explain the changes found in the other objectives. Objective 6: Determine the safety of the diets that increase the ketone bodies compared to the classic hypocaloric diet, Objective 7: if the effects of the different dietary approaches are maintained during the medium time, and Objective 8: Verify in experimental models (microbiota transplants from humans with different diets to germ-free mice, ketosis dietary models, and ketone bodies administration) the causality of the gut microbiota of these findings.

Methodology: Model 1: Dietary intervention in humans with 4 types of diet with a different increase of the ketone bodies: classic hypocaloric diet (DH); diet with 8h of feeding and 16h of starving in periods of 24h (D16); diet with intermittent caloric restriction (DA); and normal in protein and low in carbohydrates hypocaloric ketogenic diet (DC).

Condition or Disease Intervention/Treatment Phase
  • Other: Standard hypocaloric die
  • Other: Intermittent fasting 16/8 (early fasting)
  • Other: Intermittent fasting 16/8 (late fasting)
  • Other: Alternate-day fasting
  • Other: Ketogenic diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Ketone Bodies and Gut Microbiota Role in the Dietetic Approach of Obesity
Actual Study Start Date :
Jan 22, 2020
Actual Primary Completion Date :
Jun 9, 2022
Actual Study Completion Date :
Jun 22, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Standard hypocaloric diet

Mediterranean diet based on olive oil as main fat and regular consumption of vegetables (2 daily rations), fruits 3 daily rations), legumes (3 weekly rations), fish (3 weekly rations), with low consumption of red meat and meat products (less than twice a week), dairy foods (less than once a week) and no sweets, pastries or sugary drinks. Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein distributed in at least 4 meals (breakfast, lunch, afternoon snack and dinner).

Other: Standard hypocaloric die
Standard hypocaloric diet

Experimental: Intermittent fasting 16/8 (early fasting)

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 12 am. to 8 pm.), maintaining 16 fasting hours (from 8 pm. to 12 am. the following day).

Other: Intermittent fasting 16/8 (early fasting)
Intermittent fasting 16/8 (early fasting)

Experimental: Intermittent fasting 16/8 (late fasting)

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 8 am. to 4 pm.), maintaining 16 fasting hours (from 4 pm. to 8 am. the following day).

Other: Intermittent fasting 16/8 (late fasting)
Intermittent fasting 16/8 (late fasting)

Experimental: Alternate-day fasting

In this diet subjects alternate norm caloric diet during 24 h (according to Harris-Benedict equation) and a diet including only 25% of caloric requirements the following 24 h (this day diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein).

Other: Alternate-day fasting
Alternate-day fasting

Experimental: Ketogenic diet

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein.

Other: Ketogenic diet
Ketogenic diet

Outcome Measures

Primary Outcome Measures

  1. Changes in gut microbiota composition [Baseline, 12 weeks]

    To evaluate changes in gut microbiota composition from baseline using different strategies for weight loss which increase ketone bodies in comparison to a standard hypocaloric diet. Change from baseline in 16S rRNA amplicons of fecal community DNA at 3 months and 6 months

Secondary Outcome Measures

  1. Changes in weight [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on anthropometric parameters in comparison to a standard hypocaloric diet

  2. Changes in body mass index. [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on body mass index in comparison to a standard hypocaloric diet

  3. Changes in waist circumference. [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on the waist circumference in comparison to a standard hypocaloric diet

  4. Changes in body composition. [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on anthropometric parameters in comparison to a standard hypocaloric diet measured by bioelectrical impedance analysis

  5. Changes in brown adipose tissue. [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on brown adipose tissue in comparison to a standard hypocaloric diet, measured by Positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG PET).

  6. Changes in uncoupling protein 1 (UCP1) [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on brown adipose tissue UCP1 in comparison to a standard hypocaloric diet using a sample of subcutaneous white adipose tissue assessed by mRNA qPCR.

  7. Changes in physical activity. [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on physical activity in comparison to a standard hypocaloric diet measured by accelerometry

  8. Changes in blood pressure [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies over the cardiovascular system in comparison to a standard hypocaloric diet based on blood pressure

  9. Changes in the punctuation in neurocognitive test [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on neurocognition, in comparison to a standard hypocaloric diet, measured by neurocognitive test

  10. Changes in heart rate [Baseline, 12 weeks]

    To analyze the effect of hypocaloric diets which increase ketone bodies on heart function measured by heart rate in comparison to a standard hypocaloric diet, measured by Holter.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Obesity (BMI≥30-45 kg/m2)
Exclusion Criteria:
  • Type 2 diabetes mellitus

  • Patients with major cardiovascular events in the 6 months prior to the study beginning.

  • Previous or current history of inflammatory disease.

  • Active infectious disease.

  • The refusal of the patient to participate in the study

  • Consumption of probiotics or prebiotics

  • Antibiotic therapy in the 3 months prior to the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virgen de la Victoria Hospital Malaga Spain 29010

Sponsors and Collaborators

  • Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Investigators

  • Principal Investigator: Francisco J. Tinahones, PhD, Instituto de Investigación Biomédica de Málaga (IBIMA).

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
ClinicalTrials.gov Identifier:
NCT04453150
Other Study ID Numbers:
  • ISCIII CP18/01160
First Posted:
Jul 1, 2020
Last Update Posted:
Jul 6, 2022
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022